Introduction

In pharmaceutical analysis, two of the most commonly performed tests are assay testing and purity testing. Although these terms are often mentioned together, they answer very different questions about a pharmaceutical product.  Both tests are essential components of quality control programs and are used throughout drug development, manufacturing, release testing, and stability studies. Understanding the distinction between assay and purity testing is fundamental for anyone involved in HPLC method development, pharmaceutical analysis, or regulatory compliance.

What Is an Assay?

An assay measures the amount, concentration, or potency of the active pharmaceutical ingredient (API) present in a sample.  In simple terms, an assay answers the question:  "How much of the intended drug substance is present?"

The purpose of an assay is to verify that a drug product contains the correct amount of active ingredient as specified by its formulation and approved label claim.

Examples of Assay Testing

Assay methods may be used to determine:

• Active ingredient content in tablets
• Drug concentration in injectable products
• API content in ophthalmic solutions
• Potency of pharmaceutical raw materials
• Concentration of an active ingredient during manufacturing

For example, a tablet labeled to contain 100 mg of an API may be tested to verify that the actual content falls within the acceptable specification range.

What Is Purity Testing?

Purity testing focuses on substances present in addition to the active ingredient.  Rather than measuring how much API is present, purity testing answers the question:  "What else is in the sample?"  These unwanted components are commonly referred to as impurities.  Purity testing helps determine whether impurities are present at acceptable levels and whether a pharmaceutical product meets established quality requirements.

Common Types of Impurities

Impurities can originate from a variety of sources.

Related Substances

Chemically similar compounds that may result from:

• Manufacturing processes
• Synthetic intermediates
• Side reactions

Degradation Products

Compounds formed when an API breaks down due to:

• Heat
• Light exposure
• Oxidation
• Moisture
• Long-term storage

Residual Solvents

Trace amounts of solvents remaining from manufacturing operations.

Process Impurities

Materials introduced during synthesis, purification, or manufacturing that remain at low levels in the finished product.

Assay vs. Purity: A Simple Comparison

Assay

Measures:  Active pharmaceutical ingredient
Primary Question:  How much of the drug is present?
Purpose:  Verify potency and dosage accuracy
Typical Result:

• Percent label claim
• Concentration value
• Potency value

Purity Test

Measures:  Impurities and related compounds
Primary Question:  What impurities are present and at what level?
Purpose:  Evaluate product quality and safety
Typical Result:

• Individual impurity levels
• Total impurity content
• Related substances profile

How HPLC Is Used

High Performance Liquid Chromatography (HPLC) is one of the most widely used techniques for both assay and purity testing.

HPLC Assay Methods

Assay methods are commonly optimized to provide:

• Accurate quantitation of the API
• Good precision
• Excellent reproducibility
• Reliable peak integration

The focus is generally on the principal active ingredient.

HPLC Purity Methods

Purity methods are typically optimized to:

• Detect low-level impurities
• Separate closely related compounds
• Identify degradation products
• Quantify trace contaminants

In many cases, purity methods require greater chromatographic resolution than assay methods.

Why Both Tests Are Important

A product may pass one test and fail the other.  For example:

• A tablet may contain the correct amount of active ingredient (passes assay).
• The same tablet may contain excessive impurities (fails purity testing).

Likewise:

• A product may exhibit very low impurity levels (passes purity).
• The active ingredient concentration may be below specification (fails assay).

For this reason, assay and purity testing complement one another and are often performed together as part of a comprehensive pharmaceutical quality program.

Regulatory Importance

Regulatory agencies expect pharmaceutical manufacturers to demonstrate both:

• Correct API content
• Acceptable impurity levels

Assay and purity testing support:

• Product release
• Stability studies
• Method validation
• Manufacturing quality control
• Regulatory submissions
• Ongoing product monitoring

These tests help ensure that pharmaceutical products remain both safe and effective throughout their lifecycle.

Industry Guidance

Several internationally recognized guidance documents address assay and impurity testing.

Validation of Analytical Procedures

ICH Q2(R2)  Provides guidance for validating analytical methods used in pharmaceutical testing.

Impurity Testing

ICH Q3A  Addresses impurities in new drug substances.
ICH Q3B  Addresses impurities in finished drug products.  These documents provide frameworks for establishing analytical procedures, acceptance criteria, and reporting requirements.

Key Takeaways

• An assay measures the amount or potency of the active pharmaceutical ingredient.
• A purity test evaluates impurities, degradation products, and related substances.
• Assay answers the question: "How much API is present?"
• Purity testing answers the question: "What else is present?"
• Both tests are critical for pharmaceutical quality control.
• HPLC is widely used for both assay and purity determinations.
• Together, assay and purity testing help verify the safety, quality, and effectiveness of pharmaceutical products